跳至主要内容
临床试验/NCT03007472
NCT03007472已完成不适用

Clinical Evaluation of the Cochlear Nucleus(R) CI532 Cochlear Implant in Adults

Cochlear19 个研究点 分布在 1 个国家目标入组 96 人开始时间: 2017年2月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Cochlear
入组人数
96
试验地点
19
主要终点
Change From Pre- to 6 Months Post-implantation Speech Recognition in Quiet in the Implanted Ear Alone

研究概览

简要总结

The purpose of this study is to gather long-term data on the FDA approved CI532 cochlear implant, and CP1000 (Nucleus 7) sound processor

详细描述

Appropriate candidates will receive a CI532 cochlear implant and be fit with the CP1000 sound processor. Imaging will be completed pre-op, intra-op, and post-op to assess implant location. Speech perception testing as well as subjective questionnaires will be administered over 12 months.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Adults 18 years or older who have a bilateral postlinguistic sensorineural hearing loss.
  • Limited benefit from amplification as defined by test scores of 40% correct or less in the ear to be implanted and 50% or less in the contralateral ear on a recorded monosyllabic word test I. Consistent with the Minimum Speech Test Battery (2011), it is required that all subjects be evaluated at 60 dBA presentation level.
  • Bilateral moderate sloping to profound hearing loss
  • Minimum of 30 days experience with appropriately fit bilateral amplification, fit using the standardized National Acoustics Laboratory (NAL) fitting method
  • Proficient in English
  • Ability to complete testing -

排除标准

  • Previous cochlear implantation
  • Pre-linguistically deafened (onset of hearing loss at less than two years of age)
  • Ossification or any other cochlear anomaly that might prevent complete insertion of the electrode array
  • Duration of severe to profound hearing loss greater than 20 years
  • Diagnosis of retro-cochlear pathology
  • Diagnosis of auditory neuropathy
  • Unrealistic expectations on the part of the subject regarding the possible benefits, risks, and limitations that are inherent to the surgical procedure and use of the prosthetic device
  • Unwillingness or inability to comply with all investigational requirements
  • Additional cognitive, medical or social handicaps that would prevent completion of all study requirements-

结局指标

主要结局

Change From Pre- to 6 Months Post-implantation Speech Recognition in Quiet in the Implanted Ear Alone

时间窗: Preoperatively and 6 months post sound processor activation

Group mean Consonant Nucleus Consonant (CNC) word recognition in quiet measured pre-operatively and again at 6 month post sound processor activation compared to the group mean score in the preoperative, best unilateral condition. The CNC word test has a score range of 0-100% with higher values indicating better scores.

次要结局

  • Change in Pre and Post Implantation Score on the Health Utility Index-3 (HUI3)(Preoperatively and 6 months post sound processor activaton)
  • Evaluation of Change in Pre and Post Implantation Speech Recognition in Noise Scores in the Implanted Ear Alone(Preoperatively and 6 months post sound processor activation)

研究者

发起方
Cochlear
申办方类型
Industry
责任方
Sponsor

研究点 (19)

Loading locations...

相似试验

Clinical Evaluation of the Cochlear Nucleus CI532... | 临床试验